Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular Endothelial Growth Factor D (VEGF-D) is a secreted glycoprotein and a member of the PDGF/VEGF family. It plays a crucial role in angiogenesis, lymphangiogenesis, and endothelial cell growth. VEGF-D undergoes proteolytic maturation and binds to VEGFR-2 and VEGFR-3 receptors. It is implicated in tumor metastasis and cardiovascular disease, making it a potential therapeutic target.
VEGF-D binds and activates VEGFR-2 and VEGFR-3 receptors, initiating downstream signaling cascades that promote angiogenesis and lymphangiogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Endothelial Growth Factor D (VEGF-D).